(Leah Hogsten | The Salt Lake Tribune) A grow house at the Realm of Caring facility in Colorado Springs, Colo., in October 2013. Starting in July, a new law will allow some Utah families of children with epilepsy to import cannabis oil from Colorado. But children who use the oil may be disqualified from enrolling in an upcoming trial of pharmaceutical-grade cannabis oil at Primary Children's Hospital in Salt Lake City.
Health Primary Childrens wins contract to study anti-seizure drug made from cannabis.
Neurologists at Primary Childrens Hospital are one step closer to being able to prescribe pharmaceutical-grade cannabis to children and teens with severe epilepsy.
Only those who apply to be part of a drug trial will be eligible 25 spots are available and its not known when the study will start.
How to sign up for cannabis
Children will be enrolled in the Epidiolex drug trial on the advice of neurologists, who will draw study participants from their patient pool at Primary Childrens Hospital.
Starting July 8, Utahns with untreatable epilepsy, children and adults, will be able to apply for a hemp supplement registration card authorizing them to import whole-plant cannabidiol extracts from states such as Colorado.
They must first obtain a letter from their doctor documenting their diagnosis. Utah law leaves it up to individual doctors whether to write such letters.
The studys lead author, neurologist Francis Filloux, is waiting for a license from the Drug Enforcement Administration freeing him to handle Schedule 1 substances, said Ed Clark, chief medical officer at Primary Childrens.
Link:
Utah hospital will use cannabis extract to treat kids with epilepsy